Neurobo Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $4 |
Gross Profit | -6 | -4 | ||
EBITDA | -6,254 | -10,078 | -6,877 | -2,411 |
EBIT | -6,259 | -10,084 | -6,881 | -2,415 |
Net Income | -5,652 | -10,053 | -6,714 | -5,314 |
Net Change In Cash | 0 | 0 | 0 | 4 |
Free Cash Flow | -5,589 | -7,254 | -6,447 | -3,402 |
Cash | 21,669 | 27,934 | 15,988 | 22,435 |
Basic Shares | 10,214 | 5,428 | 5,089 | 5,079 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $7 | $0 | $0 | $0 |
Gross Profit | -28 | -72 | -67 | |
EBITDA | -15,880 | -11,398 | -15,250 | -29,670 |
EBIT | -15,886 | -11,426 | -15,298 | -29,716 |
Net Income | -12,470 | -6,115 | -15,222 | -29,593 |
Net Change In Cash | 7 | 0 | 0 | 0 |
Free Cash Flow | -10,849 | -11,712 | -15,137 | -10,768 |
Cash | 22,435 | 33,364 | 16,387 | 10,089 |
Basic Shares | 5,071 | 321 | 96 | 67 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.55 |
2024-06-30 | -$1.85 |
2024-03-31 | -$1.32 |
2023-12-31 | -$2.28 |
